(Q46573452)

23 December 2017

title

Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (Copaxone). (English)

1 reference

23 December 2017

0 references

3

1 reference

23 December 2017

author name string

C Iarlori

1

1 reference

23 December 2017

D Gambi

2

1 reference

23 December 2017

A Patruno

4

1 reference

23 December 2017

M Felaco

5

1 reference

23 December 2017

M Salvatore

6

1 reference

23 December 2017

L Speranza

7

1 reference

23 December 2017

M Reale

8

1 reference

23 December 2017

publication date

27 May 2008

1 reference

23 December 2017

Multiple Sclerosis Journal

published in

1 reference

23 December 2017

volume

14

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

739-748

1 reference

23 December 2017

Nitric oxide synthase: expression and expressional control of the three isoforms.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Immunological patterns identifying disease course and evolution in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

The role of nitric oxide in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Serum inflammatory markers and clinical/MRI markers of disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Antioxidants in multiple sclerosis: do they have a role in therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Inducible nitric oxide synthase in chronic active multiple sclerosis plaques: distribution, cellular expression and association with myelin damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Blood-brain barrier disruption in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

European/Canadian multicenter, double-blind, randomized, placebo-controlled study of the effects of glatiramer acetate on magnetic resonance imaging-measured disease activity and burden in patients with relapsing multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Th1 and Th2 lymphocyte migration across the human BBB is specifically regulated by interferon beta and copolymer-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factorin situ

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Cytokine secretion and nitric oxide production by mononuclear cells of patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Monocyte inducible nitric oxide synthase in multiple sclerosis: regulatory role of nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

Role of nitric oxide in the regulation of T cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458508088918

21 January 2018

Identifiers

DOI

10.1177/1352458508088918

1 reference

23 December 2017

PubMed ID

18505779

1 reference

23 December 2017